About Us
Our Story
Team
Careers
News
Partner with us
Forgot password?
Sign in
Login
Login
Email
Password
Forgot your password?
Join VuMedi
Select specialty
Select specialty
Allergy, Asthma, Immunology
Anesthesiology
Cardiovascular
Dental
Dermatology
Emergency Medicine
Endocrinology
Gastroenterology & Hepatology
General Surgery
Hematology
Infectious Disease
Medical Genetics
Nephrology
Neurology
Neurosurgery
Obstetrics/Gynecology
Oncology
Ophthalmology
Oral Maxillofacial
Orthopaedics
Otolaryngology
Pathology
Pediatrics
Physical Medicine & Rehab
Plastic Surgery
Podiatry
Preventive Medicine
Primary Care
Psychiatry
Pulmonology
Radiology
Rheumatology
Urology
First name
Last name
Email
Choose Password
Confirm Password
C
What Are The New Developments in Insulin Therapy for T1D? What Will Be The Future of T2D Therapy?
By
Chantal Mathieu
December 2, 2020
0 Comments
Login to view comments.
Click here to Login
Related Content
AUTOPLAY
ON
17:21
Ilene Fennoy
Obesity and Diabetes in Children
23:47
National Lipid Association
The Ketogenic Diet - Where Does the Evidence Stand for ASCVD risk?
Feat.
C. Kirkpatrick
21:10
National Lipid Association
Plant-based Diets for Improving Lipids
Feat.
K. Williams
10:02
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When to Use Combinatio…
Feat.
G. Umpierrez
09:39
Scripps Health
Insulin Delivery Advances: What Are the Benefits of Connected Insulin Pen …
Feat.
D. Ahn
18:18
Cardiometabolic Health Congress (CMHC)
Diabetic Kidney Disease ADA Guidelines for Early Recognition & Screening
Feat.
J. Mcgill
26:17
John Tayek
2020 Updates on Insulin Therapy: What Are the Current ADA Standards of Car…
08:43
Scripps Health
How Can Physician-Patient Relationship Affect Diabetes Medication Adherenc…
Feat.
T. Santos Cavaiola
07:20
Cardiometabolic Health Congress (CMHC)
Cardiometabolic Medicine: Does SGLT2i Improve HFrEF Symptoms, QOL, Reduce …
Feat.
K. Ferdinand
09:00
Cardiometabolic Health Congress (CMHC)
63 y/o Male With BP 162/86 mmHg, 84 bpm Heart Rate, Dyspnea, PMH-Hypertens…
Feat.
R. Agarwal,
J. Mcgill
09:19
Cardiometabolic Health Congress (CMHC)
Q&A on Cardiorenal Protection With SGLT-2 Inhibitors in T2DM and Beyond
Feat.
G. Bakris,
S. Wiviott,
R. Eckel
32:17
Cardiometabolic Health Congress (CMHC)
How and Whom to Screen for NAFLD/NASH? Which Are the High-Risk Groups for …
Feat.
F. Kanwal
12:55
Emory Diabetes Education Training Academy
Insulin Treatment in Patients with Type 2 Diabetes: When and How to Start …
Feat.
G. Umpierrez
11:06
Cardiometabolic Health Congress (CMHC)
ACC Guidelines on Diabetes, CVD & CKD: Will SGLT-2i Become a SoC in HFrEF?…
Feat.
S. Wiviott
06:38
Emory Diabetes Education Training Academy
In-Hospital Management of Diabetes: What Is the Efficacy of Basal Plus Cor…
Feat.
G. Umpierrez
24:16
Cardiometabolic Health Congress (CMHC)
Metabolic Surgery for Diabetes & CV Disease: Is There a Benefits for Patie…
Feat.
D. Cummings
32:36
Physicians Committee for Responsible Medicine
2020 Update on Nutrition & Cardiometabolic Health: Which Diet Works Best a…
Feat.
H. Kahleova
19:46
Cardiometabolic Health Congress (CMHC)
ASCVD Risk Reduction Recommendations: Who Benefits From High Intensity Sta…
Feat.
M. Minissian
31:29
Scripps Health: 2020 Updates in Diabetes Management
5-Pillar Approach to Weight Loss in Diabetes: ADA Dietary & Exercise Recom…
Feat.
S. Harris
08:37
Stanford Medicine
COVID-19, Insulin Dosing & Therapeutic Inertia: Why Is it so Hard for Pati…
Feat.
J. Shubrook
